311
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The Flawed Reliance on Randomized Controlled Trials in Studies of HIV Behavioral Prevention Interventions for People Who Inject Drugs and Other Populations

, &

REFERENCES

  • Adam, B. D. (1995). The rise of a gay and lesbian movement (Revised ed.). New York: Twayne Publishers.
  • Allen, S., Meinzen-Derr, J., Kautzman, M., Zulu, I., Trask, S., Fideli, U., & Haworth, A. (2003). Sexual behavior of HIV discordant couples after HIV counseling and testing. Aids, 17(5), 733–740. doi:10.1097/01.aids.0000050867.71999.ed
  • Anderson, W. (1991). The New York Needle Trial: the politics of public health in the age of AIDS. American Journal of Public Health, 81(11), 1506–1517.
  • Assessing the Social and Behavioral Science Base for HIV/AIDS Prevention and Intervention: Workshop Summary—Background Papers. (1995). (Institute of Medicine & Workshop Committee on the Social and Behavioral Science Base for HIV/AIDS Prevention and Intervention Eds.). Washington, DC: National Academy Press.
  • Bryant, J., & Hopwood, M. (2009). Secondary exchange of sterile injecting equipment in a high distribution environment: a mixed method analysis in south east Sydney, Australia. International Journal of Drug Policy, 20(4), 324–328. doi:10.1016/j.drugpo.2008.06.006
  • Darke, S. (1998). Self-report among injecting drug users: a review. Drug and Alcohol Dependence, 51(3), 253–263.
  • Des Jarlais, D. C., Lyles, C., & Crepaz, N. (2004). Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. American Journal of Public Health, 94(3), 361–366.
  • Duong, Y. T., Qiu, M., De, A. K., Jackson, K., Dobbs, T., Kim, A. A., & Parekh, B. S. (2012). Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One, 7(3), e33328. doi:10.1371/journal.pone.0033328
  • El-Bassel, N., Gilbert, L., Wu, E., Witte, S. S., Chang, M., Hill, J., & Remien, R. H. (2011). Couple-based HIV prevention for low-income drug users from New York City: a randomized controlled trial to reduce dual risks. Journal of Acquired Immune Deficiency Syndromes, 58(2), 198–206. doi:10.1097/QAI.0b013e318229eab1
  • Fonner, V. A., Denison, J., Kennedy, C. E., O'Reilly, K., & Sweat, M. (2012). Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries. Cochrane Database of Systematic Reviews, 9, CD001224. doi:10.1002/14651858.CD001224.pub4
  • Freire, P. (1970). Pedagogy of the Oppressed. New York: Continuum.
  • Friedman, S. R., Bolyard, M., Maslow, C., Mateu-Gelabert, P., & Sandoval, M. (2005). Harnessing the power of social networks to reduce HIV risk. Focus, 20(1), 5–6.
  • Friedman, S. R., Bolyard, M., Mateu-Gelabert, P., Goltzman, P., Pawlowicz, M. P., Singh, D. Z., & Flom, P. L. (2007). Some data-driven reflections on priorities in AIDS network research. AIDS Behavior, 11(5), 641–651. doi:10.1007/s10461-006-9166-7
  • Friedman, S. R., Curtis, R., Neaigus, A., Jose, B., & Des Jarlais, D. C. (1999). Social networks, drug injectors’ lives, and HIV/AIDS. New York: Kluwer/Plenum.
  • Friedman, S. R., de Jong, W., Rossi, D., Touze, G., Rockwell, R., Des Jarlais, D. C., & Elovich, R. (2007). Harm reduction theory: users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups. International Journal of Drug Policy, 18(2), 107–117. doi:10.1016/j.drugpo.2006.11.006
  • Friedman, S. R., Des Jarlais, D. C., & Ward, T. P. (1994). Social models for changing health-relevant behavior. In R. DiClemente & J. Peterson (Eds.), Preventing AIDS: Theories & methods of behavioral interventions (pp. 95–116). New York: Plenum Press.
  • Friedman, S. R., Flom, P. L., Kottiri, B. J., Zenilman, J., Curtis, R., Neaigus, A., & Des Jarlais, D. C. (2003). Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City. Addiction, 98(2), 159–169.
  • Friedman, S. R., Maslow, C., Bolyard, M., Sandoval, M., Mateu-Gelabert, P., & Neaigus, A. (2004). Urging others to be healthy: “intravention” by injection drug users as a community prevention goal. AIDS Education and Prevention, 16(3), 250–263. doi:10.1521/aeap.16.3.250.35439
  • Friedman, S. R., Neaigus, A., Des Jarlais, D. C., Sotheran, J. L., Woods, J., Sufian, M., & Sterk, C. (1992). Social intervention against AIDS among injecting drug users. British Journal of Addiction, 87(3), 393–404.
  • Friedman, S. R., Neaigus, A., Jose, B., Curtis, R., Ildefonso, G., Goldstein, M., & Des Jarlais, D. C. (1999). Networks, Norms, and Solidaristic/Altruistic Action against AIDS among the Demonized. Sociol Focus, 32, 127–142.
  • Friedman, S. R., Neaigus, A., Jose, B., Curtis, R., Ward, T. P., & Des Jarlais, D. C. (1995). Social Models for Altering Health-Relevant Behavior. Publicacion Oficial de la Sociedad Española Interdisciplinaria de S.I.D.A., 6(3), 153–158.
  • Friedman, S. R., Sandoval, M., Mateu-Gelabert, P., Rossi, D., Gwadz, M., Dombrowski, K., & Perlman, D. (2013). Theory, measurement and hard times: some issues for HIV/AIDS research. AIDS Behavior, 17(6), 1915–1925. doi:10.1007/s10461-013-0475-3
  • Friedman, S. R., Wiebel, W., Jose, B., & Levin, L. (1993). Changing the culture of risk. In B. S. Brown, G. M. Beschner & National AIDS Research Consortium (Eds.), Handbook on risk of AIDS: Injection drug users and sexual partners (pp. 499–516). Westport, CT: Greenwood Press.
  • Friedman, S. R., & Wypijewska, C. (1995). Social Science Intervention Models for Reducing HIV Transmission. In Institute of Medicine & Workshop Committee on the Social and Behavioral Science Base for HIV/AIDS Prevention and Intervention (Eds.), Assessing the social and behavioral science base for HIV/AIDS prevention and intervention: workshop summary (pp. 53–74). Washington, DC: National Academy Press.
  • Gagnon, H., Godin, G., Alary, M., Bruneau, J., & Otis, J. (2010). A randomized trial to evaluate the efficacy of a computer-tailored intervention to promote safer injection practices among drug users. AIDS Behavior, 14(3), 538–548. doi:10.1007/s10461-009-9651-x
  • Gartlehner, G., Hansen, R. A., Nissman, D., Lohr, K. N., & Carey, T. S. (2006). A simple and valid tool distinguished efficacy from effectiveness studies. Journal of Clinical Epidemiology, 59(10), 1040–1048. doi:10.1016/j.jclinepi.2006.01.011
  • Glasgow, R. E., Lichtenstein, E., & Marcus, A. C. (2003). Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. American Journal of Public Health, 93(8), 1261–1267.
  • Goldstein, A. (1991, 21 April 1993). Clean needle programs for addicts proliferate; some are legal, others depend on uneasy truce with officials. Washington Post, p. Z6.
  • Hartel, D. M., & Schoenbaum, E. E. (1998). Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep, 113(Suppl 1), 107–115.
  • Huo, D., Bailey, S. L., Hershow, R. C., & Ouellet, L. (2005). Drug use and HIV risk practices of secondary and primary needle exchange users. AIDS Education and Prevention, 17(2), 170–184. doi:10.1521/aeap.17.3.170.62900
  • Huo, D., & Ouellet, L. J. (2007). Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study. Journal of Acquired Immune Deficiency Syndromes, 45(1), 108–114. doi:10.1097/QAI.0b013e318050d260
  • Khan, M. R., Bolyard, M., Sandoval, M., Mateu-Gelabert, P., Krauss, B., Aral, S. O., & Friedman, S. R. (2009). Social and behavioral correlates of sexually transmitted infection- and HIV-discordant sexual partnerships in Bushwick, Brooklyn, New York. Journal of Acquired Immune Deficiency Syndromes, 51(4), 470–485. doi:10.1097/QAI.0b013e3181a2810a
  • Kienle, G. S. (2005). [Is there a rationale for pluralistic evaluation models? Limitations of randomized clinical trials]. Z Arztl Fortbild Qualitatssich, 99(4–5), 289–294.
  • Kippax, S. (2012). Effective HIV prevention: the indispensable role of social science. Journal of the International AIDS Society, 15(2), 17357. doi:10.7448/IAS.15.2.17357
  • Kippax, S., Reis, E., & de Wit, J. (2011). Two sides to the HIV prevention coin: efficacy and effectiveness. AIDS Education and Prevention, 23(5), 393–396. doi:10.1521/aeap.2011.23.5.393
  • Kippax, S., & Stephenson, N. (2012). Beyond the distinction between biomedical and social dimensions of HIV prevention through the lens of a social public health. American Journal of Public Health, 102(5), 789–799. doi:10.2105/AJPH.2011.300594
  • Manhart, L. E., & Holmes, K. K. (2005). Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked? The Journal of Infectious Diseases, 191 Suppl 1, S7–24. doi:10.1086/425275
  • Neaigus, A., Friedman, S. R., Jose, B., Goldstein, M. F., Curtis, R., Ildefonso, G., & Des Jarlais, D. C. (1996). High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. Journal of Acquired Immune Deficiency Syndromes Hum Retrovirol, 11(5), 499–509.
  • Newmeyer, J. A. (1988a). Why bleach? Development of a strategy to combat HIV contagion among San Francisco intravenous drug users. NIDA Research Monograph, 80, 151–159.
  • Newmeyer, J. A. (1988b). Why bleach? Fighting AIDS contagion among intravenous drug users: the San Francisco experience. Journal of Psychoactive Drugs, 20(2), 159–163. doi:10.1080/02791072.1988.10524488
  • Padian, N. S., McCoy, S. I., Balkus, J. E., & Wasserheit, J. N. (2010). Weighing the gold in the gold standard: challenges in HIV prevention research. Aids, 24(5), 621–635. doi:10.1097/QAD.0b013e328337798a
  • Porzsolt, F., & Kliemt, H. (2008). [Ethical and empirical limitations of randomized controlled trials]. Med Klin (Munich), 103(12), 836–842. doi:10.1007/s00063-008-1132-x
  • Sanson-Fisher, R. W., Bonevski, B., Green, L. W., & D'Este, C. (2007). Limitations of the randomized controlled trial in evaluating population-based health interventions. American Journal of Preventive Medicine, 33(2), 155–161. doi:10.1016/j.amepre.2007.04.007
  • Singal, A. G., Higgins, P. D., & Waljee, A. K. (2014). A primer on effectiveness and efficacy trials. Clinical and Translational Gastroenterology, 5, e45. doi:10.1038/ctg.2013.13
  • Vlahov, D., Des Jarlais, D. C., Goosby, E., Hollinger, P. C., Lurie, P. G., Shriver, M. D., & Strathdee, S. A. (2001). Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. American Journal of Epidemiology, 154(12 Suppl), S70–77.
  • Vygotsky, L. S. (1978). Mind in society: The development of higher psychological processes In M. Cole, V. John-Steiner, S. Scribner & E. Souberman (Eds.), Cambridge, MA: Harvard University Press.
  • Weinhardt, L. S., Forsyth, A. D., Carey, M. P., Jaworski, B. C., & Durant, L. E. (1998). Reliability and validity of self-report measures of HIV-related sexual behavior: progress since 1990 and recommendations for research and practice. Archives of Sexual Behavior, 27(2), 155–180.
  • West, S. G., Duan, N., Pequegnat, W., Gaist, P., Des Jarlais, D. C., Holtgrave, D., & Mullen, P. D. (2008). Alternatives to the randomized controlled trial. American Journal of Public Health, 98(8), 1359–1366. doi:10.2105/ajph.2007.124446
  • Wiebel, W. W. (1988). Combining ethnographic and epidemiologic methods in targeted AIDS interventions: the Chicago model. NIDA Research Monograph, 80, 137–150.
  • Zaric, G. S., Barnett, P. G., & Brandeau, M. L. (2000). HIV transmission and the cost-effectiveness of methadone maintenance. American Journal of Public Health, 90(7), 1100–1111.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.